APPHIGH SIGNALFINANCIAL10-K

AppLovin underwent a major business restructuring with dramatically improved profitability metrics and a substantial reduction in R&D spending, while pivoting its product branding from AXON to Axon Ads Manager.

The company appears to have completed a significant transformation, with operating cash flow nearly doubling and stockholders' equity nearly doubling, suggesting a successful shift toward profitability. The massive reduction in R&D expenses from $638.7M to $226.5M indicates either completion of a major development phase or a strategic pivot away from heavy investment spending.

Comparing 2026-02-19 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

AppLovin delivered strong financial performance with revenue growing 16.4% to $5.5B while dramatically improving operational efficiency. The company's balance sheet strengthened considerably with stockholders' equity nearly doubling to $2.1B and current assets expanding substantially to $4.4B. Most notably, R&D expenses were cut by nearly two-thirds while operating cash flow nearly doubled to $4.0B, signaling a successful transition from growth investment mode to cash generation focus.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+95.9%
$1.1B$2.1B

Equity base grew 95.9% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Current Assets
Balance Sheet
+91.6%
$2.3B$4.4B

Current assets grew 91.6% — improving short-term liquidity or inventory/receivables build.

Operating Cash Flow
Cash Flow
+89.2%
$2.1B$4.0B

Operating cash flow surged 89.2% — exceptional cash generation, highest quality earnings signal.

R&D Expense
P&L
-64.5%
$638.7M$226.5M

R&D spending cut 64.5% — could signal cost discipline or concerning reduction in innovation investment.

Accounts Receivable
Balance Sheet
+28.6%
$1.4B$1.8B

Receivables grew 28.6% — monitor days sales outstanding for collection efficiency.

Current Liabilities
Balance Sheet
+26.1%
$1.1B$1.3B

Current liabilities rose 26.1% — increased short-term obligations, watch current ratio.

Total Assets
Balance Sheet
+23.7%
$5.9B$7.3B

Asset base grew 23.7% — expansion through organic growth, acquisitions, or capital deployment.

Revenue
P&L
+16.4%
$4.7B$5.5B

Revenue growing 16.4% — solid top-line momentum, watch margins for quality of growth.

LANGUAGE CHANGES
NEW — 2026-02-19
PRIOR — 2025-02-27
ADDED
Management's Discussion and Analysis of Financial Condition and Results of Operations 37 Item 7A.
We provide end-to-end artificial intelligence-powered ("AI") advertising solutions for businesses to reach, monetize and grow their global audience.
Our advertising solutions include a comprehensive suite of tools including: Axon Ads Manager, our user acquisition solution, is the cornerstone of our advertising solutions.
Axon Ads Manager is powered by our Axon AI advertising recommendation engine and matches advertiser demand with publisher supply through auctions at vast scale and at microsecond-level speeds.
As our distribution grows, we gain better insights for Axon AI, which then further enhances the efficiency and effectiveness of the Axon Ads Manager.
+7 more — sign up free →
REMOVED
Management's Discussion and Analysis of Financial Condition and Results of Operations 43 Item 7A.
We provide end-to-end artificial intelligence-powered ("AI") advertising solutions for businesses to reach, monetize and grow their global audience ("Advertising").
Our Advertising solutions include a comprehensive suite of tools including: AppDiscovery, our user acquisition solution, is the cornerstone of our Advertising solutions.
AppDiscovery is powered by AXON, our AI-powered advertising engine, and matches advertiser demand with publisher supply through auctions at vast scale and at microsecond-level speeds.
As our distribution grows, we gain better insights for our AXON recommendation engine, which then further enhances the efficiency and effectiveness of our Advertising solutions.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →